Want to join the conversation?
$JNJ, which competes with $CL and $PFE, said it sees 2016 sales of $70.8-71.5Bil, reflecting expected operational growth of 2.5-3.5%. Excluding impact of acquisitions, divestitures and hepatitis C sales, operational sales growth is expected to be 4.5-6%. $JNJ sees adjusted EPS of $6.43-6.58, reflecting operational growth estimate of 5.3-7.7%.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.